Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Brachydactyly-mesomelia-intellectual disability-heart defects syndrome is a rare, genetic, multiple congenital anomalies/dysmorphic syndrome characterized by developmental delay, intellectual disability, thin habitus with narrow shoulders, mesomelic shortness of the arms, craniofacial dysmorphism (e.g. long lower face, maxillary hypoplasia, beak nose, short columella, prognathia, high arched palate, obtuse mandibular angle), brachydactyly (mostly involving middle phalanges) and cardiovascular anomalies (i.e. aortic root dilatation, mitral valve prolapse).
Biomarker and diagnostic research for brachydactyly-mesomelia-intellectual disability-heart defects syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for brachydactyly-mesomelia-intellectual disability-heart defects syndrome.
282 publications have been identified in PubMed for brachydactyly-mesomelia-intellectual disability-heart defects syndrome. Kisho has analyzed 70 by research type. Research spans Review / Meta-Analysis (63%), Basic Science / Preclinical (19%), and Case Report / Case Series (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 44 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:46 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 13 | 19% |
Patient case studies | 8 | 11% |
Disease patterns and progression | 3 | 4% |
Testing and diagnosis research | 2 | 3% |
Xu X (2026). [PMID: 42138082](https://pubmed.ncbi.nlm.nih.gov/42138082/). *J Clin Invest*. [Basic Science / Preclinical]
Elsherbini A (2026). [PMID: 41689580](https://pubmed.ncbi.nlm.nih.gov/41689580/). *J Hand Surg Am*. [Review / Meta-Analysis]
Richert Q (2026). [PMID: 41619932](https://pubmed.ncbi.nlm.nih.gov/41619932/). *Chest*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Ngulube MM (2026). [PMID: 40198060](https://pubmed.ncbi.nlm.nih.gov/40198060/). *Unknown Journal*. [Basic Science / Preclinical]
Mullen MP (2025). [PMID: 39603521](https://pubmed.ncbi.nlm.nih.gov/39603521/). *J Pediatr*. [Basic Science / Preclinical]
Hingar S (2025). [PMID: 40409799](https://pubmed.ncbi.nlm.nih.gov/40409799/). *Adv Genet*. [Review / Meta-Analysis]
Devlin LA (2025). [PMID: 40254346](https://pubmed.ncbi.nlm.nih.gov/40254346/). *Curr Top Dev Biol*. [Review / Meta-Analysis]
Paller AS (2025). [PMID: 40184496](https://pubmed.ncbi.nlm.nih.gov/40184496/). *Br J Dermatol*. [Review / Meta-Analysis]
Van't Hoff C (2025). [PMID: 41308001](https://pubmed.ncbi.nlm.nih.gov/41308001/). *J Frailty Aging*. [Review / Meta-Analysis]